Items where authors include "Gaunt, P."

Jump to: Article
Number of items: 7.

Article

Simões, R. orcid.org/0000-0003-3874-3128, Gulliford, S., Seddon, B. et al. (13 more authors) (2024) Predicting radiotherapy response, toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose–volume constraints development: a study protocol. BMJ Open, 14 (8). e083617. ISSN 2044-6055

Woll, P.J. orcid.org/0000-0002-1118-0831, Gaunt, P., Gaskell, C. et al. (12 more authors) (2023) Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata. British Journal of Cancer, 129 (9). pp. 1490-1499. ISSN 0007-0920

Woll, P., Gaunt, P., Danson, S. et al. (8 more authors) (2022) Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP) : a randomised, double-blind, placebo-controlled phase II trial. Lung Cancer, 171. pp. 26-33. ISSN 0169-5002

Woll, P.J., Gaunt, P., Danson, S. orcid.org/0000-0002-3593-2890 et al. (8 more authors) (2022) Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP) : a randomised, double-blind, placebo-controlled phase II trial. SSRN. (Submitted)

Homer, V., Yap, C., Bond, S. et al. (16 more authors) (2022) Early phase clinical trials extension to guidelines for the content of statistical analysis plans. The BMJ, 376. e068177. ISSN 0959-8138

Forker, L., Gaunt, P., Sioletic, S. et al. (13 more authors) (2018) The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma. British Journal of Cancer, 118 (5). pp. 698-704. ISSN 0007-0920

Ferry, D., Billingham, L., Jarrett, H. et al. (16 more authors) (2017) Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial. European Journal of Cancer, 83. pp. 302-312. ISSN 0959-8049

This list was generated on Wed Apr 2 02:23:46 2025 BST.